交易中 07-31 10:54:54 美东时间
-0.010
-10.77%
Jupiter Neurosciences, Inc. ( ($JUNS) ) has provided an announcement. Between M...
07-29 05:50
Agreement expands Jupiter from a single-program company into a dual clinical-stage CNS developer. Management believes the transaction strengthens the Company through diversification across two-clinical-stage CNS assets; expanding its portfolio to include both its natural resveratrol program and a No...
07-21 19:16
Jupiter Neurosciences has entered a $100M agreement with PharmAla Biotech for exclusive U.S. rights to ALA-002, a novel MDMA-based therapeutic targeting PTSD and anxiety. The deal diversifies Jupiter's CNS portfolio, adding a Phase II psychedelic asset alongside its Parkinson's program, while leveraging U.S. regulatory support for psychedelic medicines.
07-21 11:13
The latest announcement is out from Jupiter Neurosciences, Inc. ( ($JUNS) ). On...
07-01 05:25
Shares of Universe Pharmaceuticals Inc (NASDAQ:UPC) rose sharply in pre-market trading after the company announced it will acquire Best Praise International for $10.75 million. Universe Pharmaceuticals shares jumped 228.4% to $9.72 in pre-market trading. Here are some other stocks moving in pre-mark...
06-29 19:03
Jupiter Neurosciences, Inc. ( ($JUNS) ) has provided an update. On May 20, 2026...
05-21 23:26
Shares of elf Beauty Inc (NYSE: ELF) rose sharply in pre-market trading after beating analyst expectations with fourth-quarter earnings of 32 cents per share and revenue of $449.29 million, up 35%. Other pre-market gainers include WHLR, ATPC, LIMN, JUNS, ILLR, NCPL, VIDA, WNW, and APLD. The biggest losers are WGRX, MMA, IPW, and CAPS.
05-21 17:21
Jupiter Neurosciences, Inc. ( ($JUNS) ) has provided an announcement. On May 19...
05-20 22:17
Gainers Silexion Therapeutics (NASDAQ:SLXN) shares moved upwards by 147.2% to ...
05-20 20:06
The shares will be subject to a 120-day Lock-up period. The term sheet also provides that additional development milestone payments and single digit royalties will be paid as the product is developed, approved and
05-20 19:49